Oramed Pharmaceuticals Inc. Financial Ratios — ORMP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-54.05	-69.52	-60.65	-37.4	-30.04	-31.7	-25.7	-29.56	-34.99	-29.03	-25.76	-25.25	2.89	-10.14	33.17
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5.95	- -	-42.89
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-8.6	- -	-7.27
Gross Margin (%)	- -	- -	- -	- -	- -	23.56	92.39	103.51	96.67	100	100	100	100	- -	0.65
EBITDA Margin (%)	- -	- -	- -	- -	- -	-1,561	-438.36	-552.1	-540.99	-433.58	-893.3	-1,499.82	-1,162.16	- -	-748.35
Operating Margin (%)	- -	- -	- -	- -	- -	-1,561.62	-438.56	-552.35	-541.29	-433.84	-896.15	-1,501.96	-1,176.79	- -	-754.4
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-222.99	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-1,502.18	-410.42	-519.68	-519.98	-424.76	-850.5	-1,393.41	379.7	- -	3,766.2
Profit Margin (%)	- -	- -	- -	- -	- -	-1,710.45	-426.71	-519.68	-531.08	-424.76	-822.72	-1,352.61	412.31	- -	3,202.5
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-1,710.45	-426.71	-519.68	-531.08	-424.76	-822.72	-1,352.61	412.31	- -	3,202.5
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.01
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	52	- -	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	51	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	1
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.02	-0.02	-3.31	-0.03	-0.06
Net Debt/EBITDA	0.63	1.54	0.53	0.3	0.44	0.39	0.37	0.37	0.23	1.64	3.2	1	-2.69	4.32	3.07
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.02	-0.02	-3.27	-0.03	-0.05
Net Debt/EBIT	0.62	1.54	0.53	0.3	0.44	0.39	0.37	0.37	0.23	1.64	3.19	1	-2.66	4.26	3.05
EBITDA to Interest Expense	-128.17	-14.41	-13.72	-536.36	- -	- -	- -	- -	- -	- -	- -	- -	-7.65	-14.76	- -
EBITDA-CapEx/Interest Expense	-128.28	-14.42	-13.73	-537.64	- -	- -	- -	- -	- -	- -	- -	- -	-7.77	-14.78	- -
EBIT to Interest Expense	-129.67	-14.48	-13.73	-536.91	- -	- -	- -	- -	- -	- -	- -	- -	-7.74	-14.98	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	- -
Common Equity/Total Assets	-334.66	-336.4	-254.38	-127.05	-132.48	-107.07	-145.52	-145.61	-233.38	-206.86	-89.4	-100.6	-71.22	-113.43	-53.26
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.35	0.43	0.21	0.11	0.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.03	-0.36	-0.4	-0.32	-0.09	-0.44
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.07	0.31	0.4	0.16	0.1	0.23
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.23	0.46	0.59	31.69	0.26	0.41
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.08	-0.47	-0.55	-48.53	-0.21	-0.68
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	0.42	0.55	23.41	0.24	0.36
Net Debt to Equity	-40.64	-117.28	-27.94	-8.47	-12.94	-14.92	-20.63	-16.06	-17.17	-58.69	-66.3	-26.77	25.76	-37.44	-23
Net Debt/Capital (%)	9.46	19.92	9.35	5.98	8.43	7.85	6.58	6.75	3.95	17.3	40.57	19.95	-36.35	23.55	27.34
EBITDA	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15
EBITDA-CapEx	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-25	-41	-16	-13	-17
Operating Income (Loss)	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	4.3	7.89	17.02	21.88	11.57	8.57	3.9	6.69	6.08	8.8	14.09	27.1	3.05	24.97	6.6
Current Ratio	9.71	8.19	17.36	22.38	11.67	8.62	3.93	6.82	6.28	8.93	14.27	27.34	3.06	25.19	6.98
Quick Ratio	5.53	8.02	17.14	22.3	11.57	8.57	3.9	6.69	6.08	8.8	14.09	27.1	3.05	24.97	6.84
CFO/Avg Current Liab	-3.79	-4.24	-5.95	-5.53	-4.02	1.82	-1.33	-3.02	-2.62	-2.53	-3.78	-4.49	-0.35	-0.29	-0.74
Common Equity/Total Assets	-334.66	-336.4	-254.38	-127.05	-132.48	-107.07	-145.52	-145.61	-233.38	-206.86	-89.4	-100.6	-71.22	-113.43	-53.26
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.35	0.43	0.21	0.11	0.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.03	-0.36	-0.4	-0.32	-0.09	-0.44
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.07	0.31	0.4	0.16	0.1	0.23
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.23	0.46	0.59	31.69	0.26	0.41
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.08	-0.47	-0.55	-48.53	-0.21	-0.68
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	0.42	0.55	23.41	0.24	0.36
CFO/Total Liabilities	-283.35	-151.7	-641.97	-403.17	-324.12	27.97	-29.94	-90	-84.74	-105.84	-184.47	-266.24	-17.86	-84.7	-29.39
CFO/CapEx	-782.5	-1,150.5	-566	-290.57	-4,946	517.22	-833	-2,931.4	-862.67	-151.71	-56.48	-56.29	-40.53	-467.33	-4.73
Altman's Z-Score	13.29	3.46	55.52	54.2	21.85	1.8	1.12	0.45	-1.34	0.91	28.25	25.74	0.33	5.17	1.91

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.74	0.4	-0.1	0.07	- -	- -	- -	- -	- -	3.23
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	490.89	913.48	-3,620.29	5,012.67	- -	- -	- -	- -	- -	113.16
Cash Conversion Cycle	- -	- -	- -	- -	- -	-490.89	-913.48	3,620.29	-5,012.67	- -	- -	- -	- -	- -	-113.16
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	19	23	53	94	61	91	115	74	58	72	560	469	93	99	118
- Cash & Cash Equivalents	2	4	2	2	3	4	4	5	3	19	77	40	9	54	46
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	-1	-1	-1	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	52	- -	1
Enterprise Value	17	18	44	72	44	60	95	43	26	32	467	314	-18	-44	-7
Total Capital	-14	-18	-22	-28	-35	-46	-56	-69	-81	-92	-113	-162	-106	-177	-122
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.08	-0.47	-0.55	-48.53	-0.21	-0.68
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.83	-0.01	-0.12
EV/Sales	- -	- -	- -	- -	- -	93.61	38.68	17.64	9.5	11.75	172.92	116.04	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	12.89	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	12.87	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	19	23	53	94	61	91	115	74	58	72	560	469	94	99	121
Diluted Enterprise Value	17	18	50	92	58	87	111	69	55	52	484	429	135	44	76
EV per Share	3.13	2.98	6.11	7.84	4.03	4.75	7.14	2.9	1.47	1.55	16.42	8.04	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	1	2	2	3	3	3	3	1	- -	2
TTM EBITDA	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15
TTM Operating Income	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15
TTM Cash Flow to Firm	-2	-2	-3	-4	-5	5	-6	-15	-13	-12	-21	-28	-8	-7	-9
TTM Free Cash Flow to Firm	-2	-2	-3	-4	-5	5	-6	-15	-13	-12	-21	-27	-8	-7	-7

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-11.06	-9.83	-15.5	-23.12	-12.3	19.52	-19.77	-5.03	-4.48	-5.8	-26.93	-17.11	-9.33	-11.78	-16.76
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	17	18	44	72	44	60	95	43	26	32	467	314	-18	-44	-7
Low Price	2.4	2.76	3.12	6.12	3.71	5.4	5.7	4.6	2.78	2.32	2.4	3.59	1.67	2	1.82
EV/Sales	- -	- -	- -	- -	- -	93.61	38.68	17.64	9.5	11.75	172.92	116.04	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.86	- -	1.84
Price/Earnings Average	-13.36	-6.68	-11.09	-17.4	-9.54	-8.65	-8.97	-9.11	-4.52	-6.69	-10.94	-8.39	21.27	-5.34	1.5
Price/Earnings High	-17.49	-9.29	-18.19	-51.49	-15.19	-12.37	-11.65	-13.26	-6.47	-10.79	-30.17	-15.75	100.19	-7.87	2.09
Price/Earnings Low	-8.33	-4.86	-5.31	-9.93	-5.55	-6.22	-7.24	-5.38	-3.38	-4.14	-3.07	-3.83	12.19	-4.29	1.18
Price/Book Value	-1.3	-1.27	-2.39	-3.38	-1.74	-1.98	-2.04	-1.07	-0.72	-0.78	-4.9	-2.89	-0.59	-0.56	-0.96
Price/Book Value Average	-1.44	-1.25	-2.13	-3.58	-1.98	-2.07	-1.67	-1.68	-0.8	-0.83	-2.13	-1.89	-0.75	-0.58	-0.78
Price/Book Value High	-1.89	-1.74	-3.5	-10.59	-3.15	-2.96	-2.17	-2.45	-1.15	-1.35	-5.86	-3.54	-3.52	-0.85	-1.09
Price/Book Value Low	-0.9	-0.91	-1.02	-2.04	-1.15	-1.49	-1.35	-0.99	-0.6	-0.52	-0.6	-0.86	-0.43	-0.46	-0.61
Price/Tangible Book Value	5.06	5.98	6.46	4.51	2.45	3.48	5.98	2.37	2.99	2.18	4.81	3.1	0.57	0.68	0.59
Price/Tangible Book Value Average	5.6	5.91	5.77	4.77	2.78	3.62	4.89	3.73	3.35	2.34	2.09	2.03	0.72	0.7	0.48
Price/Tangible Book Value High	7.33	8.22	9.47	14.11	4.42	5.18	6.34	5.42	4.79	3.78	5.76	3.81	3.4	1.03	0.67
Price/Tangible Book Value Low	3.49	4.3	2.77	2.72	1.62	2.6	3.94	2.2	2.5	1.45	0.59	0.93	0.41	0.56	0.38
Price/Sales	- -	- -	- -	- -	- -	142	46.88	30.08	21.44	26.44	207.28	173.56	69.5	- -	59
Price/Sales Average	- -	- -	- -	- -	- -	147.98	38.27	47.34	24	28.44	89.96	113.48	87.69	- -	48.16
Price/Sales High	- -	- -	- -	- -	- -	211.52	49.69	68.91	34.35	45.84	248.25	213.09	413.08	- -	67.07
Price/Sales Low	- -	- -	- -	- -	- -	106.35	30.89	27.95	17.95	17.58	25.28	51.79	50.24	- -	37.68
Price/Cash Flow	-11.05	-9.82	-15.48	-23.04	-12.29	19.55	-19.74	-5.03	-4.48	-5.76	-26.45	-16.8	-9.05	-11.75	-12.9
Price/Cash Flow Average	-12.23	-9.7	-13.82	-24.36	-13.94	20.38	-16.12	-7.91	-5.01	-6.19	-11.48	-10.99	-11.41	-12.11	-10.53
Price/Cash Flow High	-16	-13.5	-22.67	-72.1	-22.21	29.13	-20.93	-11.51	-7.18	-9.99	-31.68	-20.63	-53.77	-17.82	-14.67
Price/Cash Flow Low	-7.62	-7.06	-6.62	-13.91	-8.12	14.64	-13.01	-4.67	-3.75	-3.83	-3.23	-5.01	-6.54	-9.71	-8.24
Price/Free Cash Flow Average	-12.25	-9.71	-13.85	-24.45	-13.95	20.34	-16.14	-7.91	-5.02	-6.24	-11.69	-11.19	-11.78	-12.14	-13.68
Price/Free Cash Flow High	-16.02	-13.51	-22.71	-72.35	-22.21	29.07	-20.96	-11.52	-7.18	-10.05	-32.25	-21	-55.47	-17.86	-19.06
Price/Free Cash Flow Low	-7.63	-7.06	-6.64	-13.96	-8.12	14.62	-13.03	-4.67	-3.75	-3.85	-3.28	-5.11	-6.75	-9.73	-10.7
EV/Sales Average	- -	- -	- -	- -	- -	141.89	36.65	45.3	22.77	21.34	61.86	98.6	118.76	- -	25.6
EV/Sales High	- -	- -	- -	- -	- -	205.43	48.08	66.87	33.12	38.75	220.14	198.21	444.15	- -	44.51
EV/Sales Low	- -	- -	- -	- -	- -	100.26	29.27	25.91	16.72	10.48	- -	36.91	81.32	- -	15.12
EV/EBITDA Average	-8.04	-6.24	-10.39	-16.5	-8.91	-9.09	-8.36	-8.2	-4.21	-4.92	-6.92	-6.57	-10.22	-3.73	-3.42
EV/EBITDA High	-10.71	-9.29	-17.38	-49.42	-14.45	-13.16	-10.97	-12.11	-6.12	-8.94	-24.64	-13.22	-38.22	-7.54	-5.95
EV/EBITDA Low	-4.77	-4.12	-4.7	-9.29	-5	-6.42	-6.68	-4.69	-3.09	-2.42	0.32	-2.46	-7	-2.12	-2.02
EV/EBIT Average	-7.95	-6.21	-10.38	-16.48	-8.91	-9.09	-8.36	-8.2	-4.21	-4.92	-6.9	-6.56	-10.09	-3.67	-3.39
EV/EBIT High	-10.59	-9.24	-17.36	-49.37	-14.44	-13.15	-10.96	-12.11	-6.12	-8.93	-24.57	-13.2	-37.74	-7.43	-5.9
EV/EBIT Low	-4.72	-4.1	-4.7	-9.28	-5	-6.42	-6.67	-4.69	-3.09	-2.42	0.32	-2.46	-6.91	-2.09	-2
Last Price	3.48	3.84	7.29	10.14	5.62	7.21	8.65	4.95	3.32	3.49	19.68	12.03	2.31	2.42	2.85
High Price	5.04	5.28	10.68	31.73	10.15	10.74	9.17	11.34	5.32	6.05	23.57	14.77	13.73	3.67	3.24
Enterprise Value Average	19	18	45	97	66	91	90	111	62	58	167	267	159	47	51
Enterprise Value High	26	27	75	292	107	132	118	164	90	105	595	536	595	95	89
Enterprise Value Low	11	12	20	55	37	64	72	63	45	28	-8	100	109	27	30

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	6	7	8	10	12	13	14	17	17	24	35	40	40	40	39
Diluted Weighted Avg Shares	5	6	7	9	11	13	13	15	17	21	28	39	41	41	42
Basic Weighted Avg Shares	5	6	7	9	11	13	13	15	17	21	28	39	40	41	41
Revenue per Share	- -	- -	- -	- -	- -	0.05	0.18	0.16	0.15	0.13	0.09	0.07	0.03	- -	0.05
EBITDA per Share	-0.44	-0.49	-0.6	-0.64	-0.68	-0.79	-0.81	-0.91	-0.84	-0.57	-0.85	-1.04	-0.39	-0.31	-0.36
Operating Income per Share	-0.45	-0.49	-0.6	-0.64	-0.68	-0.79	-0.81	-0.91	-0.84	-0.57	-0.85	-1.04	-0.39	-0.31	-0.36
Basic EPS, GAAP	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.78	-0.94	0.14	-0.47	1.55
Basic EPS from Cont Ops	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.81	-0.97	0.13	-0.47	1.55
Diluted EPS, GAAP	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.78	-0.94	0.14	-0.47	1.51
Diluted EPS from Cont Ops	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.81	-0.97	0.13	-0.47	1.51
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.31	-0.39	-0.47	-0.44	-0.46	0.37	-0.44	-0.98	-0.74	-0.61	-0.74	-0.72	-0.26	-0.21	-0.22
Free Cash Flow per Basic Share	-0.32	-0.39	-0.47	-0.44	-0.46	0.37	-0.44	-0.99	-0.74	-0.61	-0.76	-0.73	-0.26	-0.21	-0.27
Cash & Equivalents per Share	0.35	0.86	1.18	2.3	1.59	2.46	1.51	2.05	1.85	1.94	3.31	3.99	4.02	3.47	3.04
Book Value per Share	-2.67	-3.03	-3.06	-3	-3.23	-3.63	-4.23	-4.64	-4.63	-4.5	-4.02	-4.17	-3.9	-4.31	-2.97
Tangible Book Value per Share	0.69	0.64	1.13	2.25	2.29	2.07	1.45	2.09	1.11	1.6	4.09	3.88	4.04	3.56	4.82

Oramed Pharmaceuticals Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)